BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16149446)

  • 1. [Macrophage chemotactic factor and macrophage migration inhibitory factor].
    Takahashi M
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():41-3. PubMed ID: 16149446
    [No Abstract]   [Full Text] [Related]  

  • 2. [Macrophage migration inhibition test (MIT), leukocyte migration inhibition test (LMT)].
    Shimizu Y; Nakayama Y; Hirano K
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():784-7. PubMed ID: 16111394
    [No Abstract]   [Full Text] [Related]  

  • 3. [MIP-1].
    Tanaka Y
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():37-9. PubMed ID: 16149445
    [No Abstract]   [Full Text] [Related]  

  • 4. [Macrophage chemotactic factor and macrophage migration inhibitory factor].
    Takahashi M
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():47-9. PubMed ID: 20960746
    [No Abstract]   [Full Text] [Related]  

  • 5. Macrophage inhibitory factor (MIF): properties and role in delayed-type hypersensitivity.
    Landolfo S
    G Batteriol Virol Immunol; 1977; 70(7-12):137-43. PubMed ID: 355031
    [No Abstract]   [Full Text] [Related]  

  • 6. [Macrophage chemotactic factor and macrophage migration inhibitory factor].
    Takahashi M
    Nihon Rinsho; 1999 Nov; 57 Suppl():752-4. PubMed ID: 10635961
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.
    Radstake TR; Sweep FC; Welsing P; Franke B; Vermeulen SH; Geurts-Moespot A; Calandra T; Donn R; van Riel PL
    Arthritis Rheum; 2005 Oct; 52(10):3020-9. PubMed ID: 16200611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemical mediation of delayed hypersensitivity skin reactions: III. Purification and characterization of a precursor protein for macrophage-chemotactic factor in normal guinea pig plasma.
    Ueda K; Kawaguchi T; Okamoto T; Kambara T
    Am J Pathol; 1982 Sep; 108(3):291-8. PubMed ID: 7114165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotactic macrophage subpopulations defined by macrophage chemotactic factors from delayed hypersensitivity reaction sites.
    Honda M; Yoshimura T; Watanabe T; Hayashi H
    J Immunol; 1983 Dec; 131(6):2989-94. PubMed ID: 6196408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of disease.
    Serarslan G; Yönden Z; Söğüt S; Savaş N; Celik E; Arpaci A
    Clin Exp Dermatol; 2010 Jul; 35(5):487-90. PubMed ID: 19874371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage migration inhibitory factor and glucocorticoid sensitivity.
    Aeberli D; Leech M; Morand EF
    Rheumatology (Oxford); 2006 Aug; 45(8):937-43. PubMed ID: 16705047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of macrophage migration inhibition factor (MIF) in serum of patients with prostate cancer and its clinical significance].
    Tang WM; Gou X; Liu QX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jan; 27(1):97-8. PubMed ID: 21485220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic fetal inflammation and reduced concentrations of macrophage migration inhibitory factor in tracheobronchial aspirate fluid of extremely premature infants.
    Thomas W; Seidenspinner S; Kawczyńska-Leda N; Kramer BW; Chmielnicka-Kopaczyk M; Marx A; Szymankiewicz M; Speer CP
    Am J Obstet Gynecol; 2008 Jan; 198(1):64.e1-6. PubMed ID: 18166309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis.
    Kim HR; Park MK; Cho ML; Yoon CH; Lee SH; Park SH; Leng L; Bucala R; Kang I; Choe J; Kim HY
    J Rheumatol; 2007 May; 34(5):927-36. PubMed ID: 17407222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A novel mediator--macrophage migration inhibitory factor].
    Nishihira J
    Nihon Rinsho; 2004 Dec; 62(12):2205-11. PubMed ID: 15597786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage migration inhibitory factor in cancer.
    Yasasever V; Camlica H; Duranyildiz D; Oguz H; Tas F; Dalay N
    Cancer Invest; 2007 Dec; 25(8):715-9. PubMed ID: 18058468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of macrophage migration inhibitory factor activity produced in vivo by a cell-mediated immune reaction in the guinea pig.
    Postlethywaite AE; Townes AS; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1716-20. PubMed ID: 794416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis.
    Leech M; Metz C; Santos L; Peng T; Holdsworth SR; Bucala R; Morand EF
    Arthritis Rheum; 1998 May; 41(5):910-7. PubMed ID: 9588744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review on the natural mediators of inflammatory leucotaxis.
    Hayashi H
    Acta Pathol Jpn; 1982; 32 Suppl 2():271-84. PubMed ID: 6765002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
    Sprong T; Pickkers P; Geurts-Moespot A; van der Ven-Jongekrijg J; Neeleman C; Knaup M; Leroy D; Calandra T; van der Meer JW; Sweep F; van Deuren M
    Shock; 2007 May; 27(5):482-7. PubMed ID: 17438452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.